Latest International Development News

Page 3 of 5
Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.
Ada Torres
Ada Torres
31 July 2025
Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.
Maxwell Dee
Maxwell Dee
30 July 2025
Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.
Maxwell Dee
Maxwell Dee
30 July 2025
Patrys Limited has completed a modest capital raise and restructured its leadership as it advances its deoxymab antibody program, with a larger entitlement offer announced to fund clinical development and business growth.
Ada Torres
Ada Torres
29 July 2025
Minbos Resources has secured key financing and made significant construction strides on its Angolan phosphate fertilizer plant, while rolling out promising new fertilizer blends to support local agriculture.
Maxwell Dee
Maxwell Dee
29 July 2025
Cygnus Metals reports standout drilling results at its Chibougamau project, highlighting the new Golden Eye prospect and Corner Bay deposit, supported by a strong A$18.3 million capital raise to accelerate development.
Maxwell Dee
Maxwell Dee
23 July 2025
AdAlta Limited has prioritized two promising CAR-T cellular immunotherapy products for licensing agreements and successfully raised $1.3 million to support its strategic expansion. The company’s focused capital management and pipeline refinement signal a pivotal phase in its ‘East to West’ strategy.
Ada Torres
Ada Torres
23 July 2025
Aura Energy has marked significant progress toward uranium production at its Tiris project in Mauritania, while forging a key collaboration to advance uranium exploration in Sweden amid shifting regulatory landscapes.
Maxwell Dee
Maxwell Dee
21 July 2025
EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.
Ada Torres
Ada Torres
7 July 2025
Renergen Limited reports steady LNG production despite maintenance downtime, progresses a strategic merger with ASP Isotopes, and advances exploration with new seismic data and drilling activity.
Maxwell Dee
Maxwell Dee
19 June 2025
EVT Limited has officially kicked off the sale process for its prime Sydney CBD property at 525 George Street, offering a rare mixed-use development opportunity with significant growth potential.
Eva Park
Eva Park
11 June 2025
Streamplay’s subsidiary Noodlecake has inked a three-year licensing agreement with Amazon to adapt and distribute one of its owned games on Amazon’s gaming platform, marking a strategic expansion into a new marketplace.
Sophie Babbage
Sophie Babbage
29 May 2025